U.S. Markets closed

This $90M public company is "set up" for sale, CFO says

Seth Thomas Gulledge
This $90M public company is "set up" for sale, CFO says

As one Triangle public company rapidly approaches FDA approval of its only lead drug, its executives say the company is set up for the potential – and expectation – of buy-out opportunities.